Eiger BioPharmaceuticals, Inc. (EIGR) Reaches $11.20 After 5.00% Up Move; Dean Investment Associates Has Decreased Its First Merchants (FRME) Holding

April 18, 2018 - By Dolores Ford

Dean Investment Associates Llc decreased First Merchants Corp (FRME) stake by 19.2% reported in 2017Q4 SEC filing. Dean Investment Associates Llc sold 29,592 shares as First Merchants Corp (FRME)’s stock declined 4.97%. The Dean Investment Associates Llc holds 124,500 shares with $5.24M value, down from 154,092 last quarter. First Merchants Corp now has $2.09B valuation. The stock increased 0.12% or $0.05 during the last trading session, reaching $42.19. About 61,152 shares traded. First Merchants Corporation (NASDAQ:FRME) has risen 8.92% since April 18, 2017 and is uptrending. It has underperformed by 2.63% the S&P500.

The stock of Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) is a huge mover today! The stock increased 3.23% or $0.35 during the last trading session, reaching $11.2. About 107,439 shares traded or 13.24% up from the average. Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) has declined 11.57% since April 18, 2017 and is downtrending. It has underperformed by 23.12% the S&P500.The move comes after 9 months positive chart setup for the $117.90M company. It was reported on Apr, 18 by Barchart.com. We have $11.76 PT which if reached, will make NASDAQ:EIGR worth $5.89 million more.

Eiger BioPharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on providing various products for the treatment of orphan diseases in the United States. The company has market cap of $117.90 million. The Company’s product candidate pipeline includes Lonafarnib for the treatment of hepatitis delta virus infection; PEG-interferon Lambda-1a (Lambda) for HDV infection; Exendin 9-39 for post-bariatric hypoglycemia; and Ubenimex for the treatment of pulmonary arterial hypertension and lymphedema, which are under Phase II clinical trials. It currently has negative earnings.

Analysts await Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) to report earnings on May, 11. They expect $-1.00 EPS, up 25.37% or $0.34 from last year’s $-1.34 per share. After $-1.11 actual EPS reported by Eiger BioPharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -9.91% EPS growth.

Dean Investment Associates Llc increased Verizon Communications Inc (NYSE:VZ) stake by 17,605 shares to 160,036 valued at $8.47 million in 2017Q4. It also upped Spectra Energy Partners Lp (NYSE:SEP) stake by 12,130 shares and now owns 50,697 shares. Dominion Res Inc Va (NYSE:D) was raised too.

Among 6 analysts covering First Merchants (NASDAQ:FRME), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. First Merchants had 16 analyst reports since August 18, 2015 according to SRatingsIntel. Keefe Bruyette & Woods maintained the stock with “Buy” rating in Thursday, June 1 report. The stock of First Merchants Corporation (NASDAQ:FRME) has “Buy” rating given on Wednesday, September 28 by DA Davidson. On Friday, October 6 the stock rating was initiated by Piper Jaffray with “Hold”. The rating was maintained by Keefe Bruyette & Woods with “Buy” on Monday, February 26. The firm has “Hold” rating by Piper Jaffray given on Sunday, January 28. Stephens upgraded the shares of FRME in report on Friday, January 29 to “Overweight” rating. SunTrust initiated First Merchants Corporation (NASDAQ:FRME) on Wednesday, December 16 with “Neutral” rating. The stock of First Merchants Corporation (NASDAQ:FRME) earned “Buy” rating by Keefe Bruyette & Woods on Thursday, December 21. The stock of First Merchants Corporation (NASDAQ:FRME) earned “Buy” rating by Keefe Bruyette & Woods on Tuesday, October 3. Keefe Bruyette & Woods maintained it with “Buy” rating and $52.0 target in Thursday, January 25 report.

Investors sentiment decreased to 0.81 in Q4 2017. Its down 0.54, from 1.35 in 2017Q3. It dropped, as 20 investors sold FRME shares while 64 reduced holdings. 21 funds opened positions while 47 raised stakes. 33.91 million shares or 0.71% more from 33.67 million shares in 2017Q3 were reported. Price T Rowe Associates Md holds 0% or 26,772 shares. Westover Capital Limited Liability Com invested in 6,474 shares. Emerald Mutual Fund Advisers holds 0.07% or 42,222 shares in its portfolio. Great West Life Assurance Can, Manitoba – Canada-based fund reported 5,300 shares. Lord Abbett Lc reported 839,829 shares. Lsv Asset Management owns 37,300 shares for 0% of their portfolio. 10,331 were reported by Monarch Cap Mngmt. Pnc Finance Service Group Inc holds 104,025 shares. Alps Incorporated has 12,051 shares for 0% of their portfolio. Barclays Public Ltd Liability Corporation accumulated 6,583 shares. Proshare Lc stated it has 6,085 shares. D E Shaw, a New York-based fund reported 78,654 shares. 2,280 are owned by Zurcher Kantonalbank (Zurich Cantonalbank). Ameritas Prtnrs accumulated 3,519 shares. Point72 Asia (Hong Kong) Limited reported 38 shares.

Since December 15, 2017, it had 7 insider purchases, and 1 sale for $47,533 activity. Shares for $479 were bought by Sherman Patrick A on Thursday, February 1. Lehman Gary bought $1,682 worth of First Merchants Corporation (NASDAQ:FRME) on Thursday, March 1. 3,176 First Merchants Corporation (NASDAQ:FRME) shares with value of $135,577 were bought by WALKER TERRY L. 2,219 shares were sold by Stewart Michael J, worth $94,529 on Monday, February 26.

By1 Dolores Ford